Growth Metrics

TELA Bio (TELA) Share-based Compensation (2018 - 2025)

TELA Bio has reported Share-based Compensation over the past 8 years, most recently at $812000.0 for Q4 2025.

  • Quarterly results put Share-based Compensation at $812000.0 for Q4 2025, down 25.44% from a year ago — trailing twelve months through Dec 2025 was $3.8 million (down 12.98% YoY), and the annual figure for FY2025 was $3.8 million, down 12.98%.
  • Share-based Compensation for Q4 2025 was $812000.0 at TELA Bio, down from $955000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for TELA hit a ceiling of $1.4 million in Q2 2021 and a floor of $694000.0 in Q1 2021.
  • Median Share-based Compensation over the past 5 years was $1.0 million (2022), compared with a mean of $1.0 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 185.83% in 2021 and later dropped 27.62% in 2022.
  • TELA Bio's Share-based Compensation stood at $822000.0 in 2021, then grew by 26.4% to $1.0 million in 2022, then rose by 19.44% to $1.2 million in 2023, then fell by 12.25% to $1.1 million in 2024, then dropped by 25.44% to $812000.0 in 2025.
  • The last three reported values for Share-based Compensation were $812000.0 (Q4 2025), $955000.0 (Q3 2025), and $985000.0 (Q2 2025) per Business Quant data.